Maria C Cid is an expert in Rheumatology at Hospital Clínic de Barcelona (Spain). As of October 2026, ScienceLeadR ranks Maria C Cid in the top 1% of experts worldwide for Arteritis, Vasculitis and Autoimmune Diseases. Maria C Cid has authored 375 publications, the most recent in 2026, and is an investigator in 11 clinical trials. SLR score: 1,386 (community average: 125). How the SLR is computed.

LeadR Profile

1 386 ScienceLeadR Reputation 1386
Network Map

Rheumatology

Subspecialties: Internal Medicine - Immunology - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026

Source: PubMed

University of Barcelona

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 375

Citations

Citations: 29 951 1st author: 39 Last author: 85 Unique author: 10


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis.
PMID 42625065 — vasculitis, iga vasculitis, kidney, rheumatic diseases, diagnosis, therapeutics, prognosis
Nat Rev Rheumatol Top journal20260
Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years.
PMID 42521523 — cells, glucocorticoids, safety, arteritis, rheumatic diseases, giant cells, therapeutics, giant cell arteritis
Ann Rheum Dis20260
2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis.
PMID 42481270 — vasculitis, arteritis, rheumatic diseases, therapeutics, polymyalgia rheumatica
Ann Rheum Dis20266
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.
PMID 42399125 — cells, genes, phenotype, genome-wide association study, arteritis, biomarkers, giant cells, diagnosis, giant cell arteritis
Ann Rheum Dis20260
Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki Disease.
PMID 42253052 — cells, genes, vasculitis, hemorrhage, cardiovascular system, arteries, vascular remodeling, wilms tumor, hypoxia, mucocutaneous lymph node syndrome, thrombosis, rupture, blood circulation, coronary vessels
Circulation Top journal20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 7
Phase 2 2
N/A 1
Phase 2/Phase 3 1

By status:

Completed 8
Active not recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 10
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 14

LeadR Networks

Main global connection map